Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 4:27 pm Purchase | 13G | SAGIMET BIOSCIENCES INC SER A SGMT | BAKER BROS. ADVISORS LP | 1,538,489 4.990% | 81,971 (+5.63%) | View |
2024-11-14 4:26 pm Purchase | 13G | CELCUITY INC CELC | BAKER BROS. ADVISORS LP | 1,874,978 5.100% | 1,874,978 (New Position) | View |
2024-11-14 4:24 pm Purchase | 13G | Stoke Therapeutics Inc. STOK | BAKER BROS. ADVISORS LP | 4,368,443 8.300% | 4,368,443 (New Position) | View |
2024-11-14 4:23 pm Sale | 13G | Achilles Therapeutics plc ACHL | BAKER BROS. ADVISORS LP | 0 0.000% | -3,311,567 (Position Closed) | View |
2024-11-14 4:21 pm Purchase | 13G | Nurix Therapeutics Inc. NRIX | BAKER BROS. ADVISORS LP | 6,751,565 9.700% | 1,799,113 (+36.33%) | View |
2024-11-14 4:21 pm Sale | 13G | AEROVATE THERAPEUTICS INC AVTE | BAKER BROS. ADVISORS LP | 628,939 2.200% | -1,051,578 (-62.57%) | View |
2024-11-14 4:20 pm Purchase | 13G | REPLIMUNE GROUP INC REPL | BAKER BROS. ADVISORS LP | 11,045,336 16.200% | 1,500,000 (+15.71%) | View |
2024-11-14 4:17 pm Sale | 13G | ATHIRA PHARMA INC ATHA | BAKER BROS. ADVISORS LP | 0 0.000% | -3,153,807 (Position Closed) | View |
2024-11-14 4:14 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | BAKER BROS. ADVISORS LP | 5,840,059 6.200% | 5,840,059 (New Position) | View |
2024-11-14 4:11 pm Purchase | 13G | ABCELLERA BIOLOGICS INC. ABCL | BAKER BROS. ADVISORS LP | 27,525,640 9.300% | 4,615,887 (+20.15%) | View |
2024-10-10 5:01 pm Purchase | 13D | TALIS BIOMEDICAL CORP COM TLIS | BAKER BROS. ADVISORS LP | 2,507,193 65.600% | 2,507,193 (New Position) | View |
2024-10-08 5:29 pm Purchase | 13D | Kiniksa Pharmaceuticals International plc KNSA | BAKER BROS. ADVISORS LP | 3,151,029 7.700% | 3,151,029 (New Position) | View |
2024-08-22 4:15 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | BAKER BROS. ADVISORS LP | 6,001,262 9.300% | 3,556 (+0.06%) | View |
2024-06-28 4:11 pm Purchase | 13D | KALA BIO, INC. KALA | BAKER BROS. ADVISORS LP | 891,335 19.990% | 622,122 (+231.09%) | View |
2024-06-26 4:54 pm Purchase | 13D | Entrada Therapeutics Inc. TRDA | BAKER BROS. ADVISORS LP | 4,865,819 13.200% | 161,400 (+3.43%) | View |
2024-06-14 6:52 pm Purchase | 13D | HOOKIPA PHARMA INC HOOK | BAKER BROS. ADVISORS LP | 9,813,151 9.990% | 1,664,166 (+20.42%) | View |
2024-06-14 6:23 pm Sale | 13D | INCYTE CORP INCY | BAKER BROS. ADVISORS LP | 31,209,896 16.300% | -5,459,183 (-14.89%) | View |
2024-05-28 4:16 pm Purchase | 13D | BICYCLE THERAPEUTICS PLC BCYC | BAKER BROS. ADVISORS LP | 9,399,960 19.900% | 1,710,717 (+22.25%) | View |
2024-05-13 6:06 pm Unchanged | 13D | INCYTE CORP INCY | BAKER BROS. ADVISORS LP | 36,669,079 16.300% | 0 (Unchanged) | View |
2024-05-09 6:40 pm Purchase | 13D | INCYTE CORP INCY | BAKER BROS. ADVISORS LP | 36,669,079 16.300% | 27,617 (+0.08%) | View |